Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a bedside scan and a blood test predict which newborns need intensive care?

NCT ID NCT07809971

Diagnosis Sponsor: Tanta University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 10, 2026 · Updated 1 time

Summary

Researchers are testing whether a quick lung ultrasound and a blood test for the protein ANGPTL4 can predict which late preterm and full-term newborns with breathing trouble will need NICU admission. The study includes 80 newborns born at 34 weeks or later who show signs of respiratory distress within 30 minutes of birth. Each baby receives a lung ultrasound within two hours of birth and a blood sample drawn right after. Doctors decide on NICU admission based on standard clinical care, without seeing the study measurements, so researchers can check how well the scan and blood marker match real outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
point-of-care lung ultrasound plus a blood test for the protein ANGPTL4
What this could lead to
If it works, doctors could use a quick bedside scan and a blood test to spot which newborns with breathing trouble need intensive care sooner.
What could go wrong
This is a small, single-center study of 80 newborns, so the approach may not predict NICU needs reliably in other hospitals or larger groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

80 people

The number who actually took part.

Started

Aug 2025

Finished

Aug 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

80 late preterm and term neonates with clinical evidence of respiratory distress soon after birth, at the NICU, Pediatrics Department, Tanta University Hospitals

Ages

Up to 2 hours

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

This study will include 80 late preterm and term neonates (≥34 gestional weeks) who will show any clinical signs of respiratory distress in the delivery room or within 30 minutes after birth. The exclusion criteria: 1. Preterm neonates with gestional age \<34 weeks. 2. Neonates with antenatal diagnosis of congenital anomalies of the lungs or thoracic cage. 3. Neonates with antenatal diagnosis of congenital heart disease. 4. Neonates with antenatal diagnosis of other major congenital anomalies or chromsomal abnormality. 5. Neonates born with severe perinatal asphyxia. 6. Neonates born with severe apnea requiring intubation in the delitery room.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung ultrasound score are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

newborn respiratory distress syndrome Pulmonary Atelectasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung ultrasound score Neonatal respiratory distress

Contacts and locations

Locations

  • faculty of medicine,Tanta University

    Tanta, Q2x2+cp Tanta 2, Egypt, 31527, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.